Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0L6RF
|
||||
Former ID |
DIB010484
|
||||
Drug Name |
BAY1179470
|
||||
Indication | Cancer [ICD9: 140-229; ICD10:C00-C96] | Phase 1 | [524332] | ||
Company |
Bayer healthcare pharmaceuticals
|
||||
Target and Pathway | |||||
Target(s) | Fibroblast growth factor receptor 2 | Target Info | Antagonist | [550500] | |
NetPath Pathway | IL1 Signaling Pathway | ||||
PANTHER Pathway | FGF signaling pathway | ||||
Pathway Interaction Database | FGF signaling pathway | ||||
Reactome | Activated point mutants of FGFR2 | ||||
WikiPathways | Regulation of Actin Cytoskeleton | ||||
Ectoderm Differentiation | |||||
Hair Follicle Development: Organogenesis (Part 2 of 3) | |||||
Hair Follicle Development: Induction (Part 1 of 3) | |||||
Cardiac Hypertrophic Response | |||||
Signaling Pathways in Glioblastoma | |||||
Neural Crest Differentiation | |||||
Signaling by FGFR | |||||
MicroRNAs in cardiomyocyte hypertrophy | |||||
Angiogenesis | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.